VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer.
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer. Clin Colorectal Cancer. 2014 Sep; 13(3):164-71.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor
Camptothecin
Cetuximab
Colorectal Neoplasms
Disease-Free Survival
Female
Humans
Liver Neoplasms
Lung Neoplasms
Lymphatic Metastasis
Male
Metastasectomy
Microsatellite Instability
Middle Aged
Mutation
Neoplasm Staging
Organoplatinum Compounds
Peritoneal Neoplasms
Proto-Oncogene Proteins B-raf
Survival Rate
authors with profiles
ROBERT A WOLFF
DIPEN MAHESHBHAI MARU
CATHY ENG
MICHAEL JAMES OVERMAN
DAVID FOGELMAN
BRYAN K KEE
VAN KARLYLE MORRIS
NAGESHWARA V. DASARI
EDMUND SCOTT KOPETZ